Coronavirus News: Pepcid being used in new coronavirus drug trial with anti-malaria drug

NEW YORK (WABC) -- There's a potential new treatment for COVID-19, and it might not be what many people expect.

Researchers at Northwell Health have been enrolling patients into their study of famotidine.

That's the active ingredient in Pepcid, an over-the-counter medication commonly used to alleviate heartburn.

Since March 13, the drug has been being delivered through an IV in megadoses nine times greater than the typical over-the-counter dose to patients in the trial.

The drug is being given in combination with the antimalarial hydroxychloroquine.

Researchers say some data on safety will be available in a few weeks.

MORE CORONAVIRUS COVID-19 COVERAGE



COVID-19 Help, Information and Resources

UPDATES

Grieving the lost: Tri-State residents who have died
New York state
New Jersey
Connecticut
Long Island



RELATED INFORMATION

Share your coronavirus story with Eyewitness News
Stimulus check scams and other coronavirus hoaxes
Coronavirus prevention: how clean are your hands?
Centers for Disease Control and Prevention on coronavirus
Total count of NYC COVID-19 cases based on patient address

Copyright © 2020 WABC-TV. All Rights Reserved.